Bio-Rad Laboratories, Inc. (BIO)
369.14
+13.57
(+3.82%)
USD |
NYSE |
Oct 02, 16:00
368.97
-0.17
(-0.05%)
After-Hours: 20:00
Bio-Rad Laboratories Price to Book Value : 1.376 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.376 |
| October 01, 2026 | 1.325 |
| September 30, 2026 | 1.408 |
| September 29, 2026 | 1.415 |
| September 28, 2026 | 1.408 |
| September 25, 2026 | 1.42 |
| September 24, 2026 | 1.444 |
| September 23, 2026 | 1.412 |
| September 22, 2026 | 1.415 |
| September 21, 2026 | 1.406 |
| September 18, 2026 | 1.403 |
| September 17, 2026 | 1.425 |
| September 16, 2026 | 1.413 |
| September 15, 2026 | 1.409 |
| September 14, 2026 | 1.374 |
| September 11, 2026 | 1.376 |
| September 10, 2026 | 1.374 |
| September 09, 2026 | 1.405 |
| September 08, 2026 | 1.417 |
| September 04, 2026 | 1.439 |
| September 03, 2026 | 1.446 |
| September 02, 2026 | 1.448 |
| September 01, 2026 | 1.420 |
| August 31, 2026 | 1.439 |
| August 28, 2026 | 1.445 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.453 |
| August 26, 2026 | 1.448 |
| August 25, 2026 | 1.455 |
| August 24, 2026 | 1.423 |
| August 21, 2026 | 1.416 |
| August 20, 2026 | 1.403 |
| August 19, 2026 | 1.358 |
| August 18, 2026 | 1.314 |
| August 17, 2026 | 1.324 |
| August 14, 2026 | 1.328 |
| August 13, 2026 | 1.346 |
| August 12, 2026 | 1.350 |
| August 11, 2026 | 1.328 |
| August 10, 2026 | 1.321 |
| August 07, 2026 | 1.314 |
| August 06, 2026 | 1.276 |
| August 05, 2026 | 1.296 |
| August 04, 2026 | 1.241 |
| August 03, 2026 | 1.248 |
| July 31, 2026 | 1.213 |
| July 30, 2026 | 1.218 |
| July 29, 2026 | 1.220 |
| July 28, 2026 | 1.234 |
| July 27, 2026 | 1.179 |
| July 24, 2026 | 1.172 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Thermo Fisher Scientific, Inc. | 4.596 |
| Agilent Technologies, Inc. | 6.425 |
| Danaher Corp. | 2.862 |
| Illumina, Inc. | 14.53 |
| Revvity, Inc. | 2.339 |
Price to Book Value Related Metrics
| PE Ratio | 44.72 |
| PS Ratio | 3.839 |
| Price to Free Cash Flow | 28.15 |
| Price | 369.14 |
| Earnings Yield | 2.24% |
| Market Cap | 9.870B |
| Operating PE Ratio | 42.30 |
| Normalized PE Ratio | 57.54 |